Citations (26)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (26)
Tung-Yu Tiong, Mei-lin Chan, Chun-Hua Wang, Vijesh Kumar Yadav, Narpati Wesa Pikatan, Iat-Hang Fong, Chi-Tai Yeh, Kuang-Tai Kuo & Wen-Chien Huang. (2023) Exosomal miR-21 determines lung-to-brain metastasis specificity through the DGKB/ERK axis within the tumor microenvironment. Life Sciences 329, pages 121945.
Crossref
Crossref
Zi-Jun Sun, Jing-Wen Zhao, Ming Zhao, Yuan Chen, Xin Zhang, Hai-Chang Li, Guo-Qing Wu & Da-Hong Zhang. (2023) CD3high and FoxP3− tumor-infiltrating lymphocytes in the invasive margin as a favorable prognostic marker in patients with invasive urothelial carcinoma of the bladder. Anti-Cancer Drugs 34:7, pages 844-851.
Crossref
Crossref
Yi Jin, Siwei Huang & Zhanwang Wang. (2023) Identify and validate RUNX2 and LAMA2 as novel prognostic signatures and correlate with immune infiltrates in bladder cancer. Frontiers in Oncology 13.
Crossref
Crossref
Chengcheng XU, Aqin CHEN, Chaoming MAO & Bing CUI. (2023) Construction of prognostic risk model of bladder cancer based on cuproptosis-related long non-coding RNAs. Journal of Zhejiang University (Medical Sciences) 52:2, pages 139-147.
Crossref
Crossref
Hao Liu, Zhuoqun Li, Xuan Han, Zhujun Li, Yan Zhao, Fenghua Liu, Ziyu Zhu, Yi Lv, Zhijun Liu & Nana Zhang. (2023) The prognostic impact of tumor-infiltrating B lymphocytes in patients with solid malignancies: A systematic review and meta-analysis. Critical Reviews in Oncology/Hematology 181, pages 103893.
Crossref
Crossref
Sara Wahlin, Karolina Boman, Bruce Moran, Björn Nodin, William M. Gallagher, Emelie Karnevi & Karin Jirström. (2022) Pre-clinical and clinical studies on the role of RBM3 in muscle-invasive bladder cancer: longitudinal expression, transcriptome-level effects and modulation of chemosensitivity. BMC Cancer 22:1.
Crossref
Crossref
Kyriaki Papadopoulou, Georgia-Angeliki Koliou, Dimitrios Tsimiliotis, Vassiliki Kotoula, Periklis Foukas, Anna Goussia, Marinos Tsiatas, Anastasios Visvikis, Kyriakos Chatzopoulos, Martha Nifora, Antonia Charchanti, Anna Koumarianou, Christos Christodoulou, Dimitrios Pectasides, Amanda Psyrri, Florentia Fostira, George Fountzilas & Epaminontas Samantas. (2022) Investigation of prognostic biomarkers in patients with urothelial carcinoma treated with platinum-based regimens. Urologic Oncology: Seminars and Original Investigations 40:12, pages 538.e15-538.e24.
Crossref
Crossref
Mohammad Hossein Kazemi, Maryam Sadri, Alireza Najafi, Ali Rahimi, Zeinab Baghernejadan, Hossein Khorramdelazad & Reza Falak. (2022) Tumor-infiltrating lymphocytes for treatment of solid tumors: It takes two to tango?. Frontiers in Immunology 13.
Crossref
Crossref
Stephan Ledderose, Severin Rodler, Lennert Eismann, Georg Ledderose & Carola Ledderose. (2022) Tumor-infiltrating lymphocytes predict survival in ≥ pT2 urothelial bladder cancer. Pathology - Research and Practice 237, pages 154037.
Crossref
Crossref
Veronika Friedrich & Hae Woong Choi. (2022) The Urinary Microbiome: Role in Bladder Cancer and Treatment. Diagnostics 12:9, pages 2068.
Crossref
Crossref
Lennert Eismann, Severin Rodler, Alexander Buchner, Gerald Bastian Schulz, Yannic Volz, Robert Bischoff, Benedikt Ebner, Thilo Westhofen, Jozefina Casuscelli, Raphaela Waidelich, Christian Stief, Boris Schlenker & Stephan Ledderose. (2022) Identification of the Tumor Infiltrating Lymphocytes (TILs) Landscape in Pure Squamous Cell Carcinoma of the Bladder. Cancers 14:16, pages 3999.
Crossref
Crossref
Rui Ran, Chao-Yang Gong, Zhi-Qiang Wang, Wen-Ming Zhou, Shun-Bai Zhang, Yong-Qiang Shi, Chun-Wei Ma & Hai-Hong Zhang. (2022) Long non‑coding RNA PART1: dual role in cancer. Human Cell 35:5, pages 1364-1374.
Crossref
Crossref
Toshiki Kijima, Terufumi Kubo, Daisaku Nishihara, Akinori Nukui, Yoshihiko Hirohashi, Toshihiko Torigoe & Takao Kamai. (2022) Cancer immunohistogram representing cancer-immunity cycle by immunohistochemistry predicts the efficacy of immune checkpoint inhibitors in urological cancer patients. Scientific Reports 12:1.
Crossref
Crossref
Xu Cheng, Yinhuai Wang, Yijian Li & Wentao Liu. (2022) Quantification of ferroptosis pattern in bladder carcinoma and its significance on immunotherapy. Scientific Reports 12:1.
Crossref
Crossref
Zhaopei Liu, Han Zeng, Kaifeng Jin, Yanze Yu, Runze You, Hongyi Zhang, Chunnan Liu, Xiaohe Su, Sen Yan, Yuan Chang, Li Liu, Le Xu, Jiejie Xu, Yu Zhu & Zewei Wang. (2022) TIGIT and PD-1 expression atlas predicts response to adjuvant chemotherapy and PD-L1 blockade in muscle-invasive bladder cancer. British Journal of Cancer 126:9, pages 1310-1317.
Crossref
Crossref
Cong Lai, Zhenyu Wu, Zhuohang Li, Hao Yu, Kuiqing Li, Zhuang Tang, Cheng Liu & Kewei Xu. (2021) A robust signature of immune‐related long non‐coding RNA to predict the prognosis of bladder cancer. Cancer Medicine 10:18, pages 6534-6545.
Crossref
Crossref
A. Bamias, A.S. Merseburger, Y. Loriot, N. James, E. Choy, D. Castellano, F. Lopez-Rios, F. Calabrò, M. Kramer, G. de Velasco, R. Zakopoulou, K. Tzannis & C.N. Sternberg. (2021) SAUL, a single-arm study of atezolizumab for chemotherapy-pretreated locally advanced or metastatic carcinoma of the urinary tract: outcomes by key baseline factors, PD-L1 expression and prior platinum therapy. ESMO Open 6:3, pages 100152.
Crossref
Crossref
Meng Zhou, Zicheng Zhang, Siqi Bao, Ping Hou, Congcong Yan, Jianzhong Su & Jie Sun. (2021) Computational recognition of lncRNA signature of tumor-infiltrating B lymphocytes with potential implications in prognosis and immunotherapy of bladder cancer. Briefings in Bioinformatics 22:3.
Crossref
Crossref
Ekaterina Laukhtina, Benjamin Pradere, Keiichiro Mori, Victor M. Schuettfort, Fahad Quhal, Hadi Mostafaei, Reza Sari Motlangh, Satoshi Katayama, Nico C. Grossmann, Marco Moschini, Dmitry Enikeev & Shahrokh F. Shariat. (2021) Catalog of prognostic tissue-based biomarkers in patients treated with neoadjuvant systemic therapy for urothelial carcinoma of the bladder: a systematic review. Urologic Oncology: Seminars and Original Investigations 39:3, pages 180-190.
Crossref
Crossref
Nina Andersson, Johan Ohlsson, Sara Wahlin, Björn Nodin, Karolina Boman, Sebastian Lundgren & Karin Jirström. (2020) Lymphocyte antigen 6 superfamily member D is a marker of urothelial and squamous differentiation: implications for risk stratification of bladder cancer. Biomarker Research 8:1.
Crossref
Crossref
Ekaterina Olkhov-Mitsel, Anjelica Hodgson, Stanley K. Liu, Danny Vesprini, Jane Bayani, John M.S. Bartlett, Bin Xu & Michelle R. Downes. (2020) Can immune markers help identify fast relapse in patients with muscle invasive bladder cancer?. Pathology - Research and Practice 216:11, pages 153200.
Crossref
Crossref
Makito Miyake, Shunta Hori, Takuya Owari, Yuki Oda, Yoshihiro Tatsumi, Yasushi Nakai, Tomomi Fujii & Kiyohide Fujimoto. (2020) Clinical Impact of Tumor-Infiltrating Lymphocytes and PD-L1-Positive Cells as Prognostic and Predictive Biomarkers in Urological Malignancies and Retroperitoneal Sarcoma. Cancers 12:11, pages 3153.
Crossref
Crossref
Ankeet Shah, Dominic C Grimberg & Brant A Inman. (2020) Classification of Molecular Biomarkers. Société Internationale d’Urologie Journal 1:1, pages 8-15.
Crossref
Crossref
Daiki Ikarashi, Shigehisa Kitano, Kazuyuki Ishida, Tetsuya Nakatsura, Hitoshi Shimodate, Takashi Tsuyukubo, Daichi Tamura, Renpei Kato, Tamotsu Sugai & Wataru Obara. (2020) Complete Pathological Response to Neoadjuvant Pembrolizumab in a Patient With Chemoresistant Upper Urinary Tract Urothelial Carcinoma: A Case Report. Frontiers in Oncology 10.
Crossref
Crossref
Ali Ariafar, Meisam Ghaedi, Somayeh Rezaeifard, Shadab Shahriari, Shahryar Zeighami, Abbas Ghaderi & Zahra Faghih. (2020) Clinical relevance and prognostic significance of PD-1/PD-Ls in non-metastatic bladder cancer: A role for PD-L2. Molecular Immunology 124, pages 35-41.
Crossref
Crossref
Faping Li, Hui Guo, Yishu Wang, Bin Liu & Honglan Zhou. (2020) Profiles of tumor-infiltrating immune cells and prognostic genes associated with the microenvironment of bladder cancer. International Immunopharmacology 85, pages 106641.
Crossref
Crossref